検索
ATAI Life Sciences NV
ATAIウォッチリストに追加
7.180USD
0.0000.00%
終値 07-31 16:00（ET）15分遅れの株価
2.66B時価総額
損失額直近12ヶ月PER
詳細情報 ATAI Life Sciences NV 企業名
Atai Beckley NV, formerly ATAI Life Sciences NV, is a clinical-stage biopharmaceutical company. The Company focused on developing treatments for mental health disorders. The Company's pipeline includes psychedelic and non-psychedelic compounds targeting depression, anxiety, and other unmet needs in psychiatry.
ATAI Life Sciences NVの企業情報
企業コードATAI
会社名Atai Beckley NV
上場日Jun 18, 2021
最高経営責任者「CEO」Rao (Srinivas G)
従業員数54
証券種類Ordinary Share
決算期末Jun 18
本社所在地Prof. J.H.Bavincklaan 7
都市AMSTELVEEN
証券取引所NASDAQ OMX - NASDAQ BASIC
国Netherlands
郵便番号1183 AT
電話番号31207932536
ウェブサイトhttps://www.atai.com/
企業コードATAI
上場日Jun 18, 2021
最高経営責任者「CEO」Rao (Srinivas G)
ATAI Life Sciences NVの経営陣
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Glenn Frank Short, Ph.D.
Dr. Glenn Frank Short, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
42.33K
+45.68%
Ms. Andrea Heslin Smiley
Ms. Andrea Heslin Smiley
Independent Supervisory Director
Independent Supervisory Director
4.67K
--
Mr. Christian Angermayer
Mr. Christian Angermayer
Chairman of the Supervisory Board
Chairman of the Supervisory Board
--
-100.00%
Ms. Sabrina Martucci Johnson
Ms. Sabrina Martucci Johnson
Independent Supervisory Director
Independent Supervisory Director
--
--
Dr. Amir Kalali
Dr. Amir Kalali
Independent Supervisory Director
Independent Supervisory Director
--
--
Dr. Srinivas Rao, M.D., Ph.D.
Dr. Srinivas Rao, M.D., Ph.D.
Chief Executive Officer, Co-Founder, Interim Managing Director
Chief Executive Officer, Co-Founder, Interim Managing Director
--
--
Ms. Anne Johnson
Ms. Anne Johnson
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Gerd G. Kochendoerfer
Dr. Gerd G. Kochendoerfer
Chief Operating Officer
Chief Operating Officer
--
--
Dr. Kevin James Craig, M.D.
Dr. Kevin James Craig, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Dr. Scott N. Braunstein, M.D.
Dr. Scott N. Braunstein, M.D.
Independent Supervisory Director
Independent Supervisory Director
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Glenn Frank Short, Ph.D.
Dr. Glenn Frank Short, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
42.33K
+45.68%
Ms. Andrea Heslin Smiley
Ms. Andrea Heslin Smiley
Independent Supervisory Director
Independent Supervisory Director
4.67K
--
Mr. Christian Angermayer
Mr. Christian Angermayer
Chairman of the Supervisory Board
Chairman of the Supervisory Board
--
-100.00%
Ms. Sabrina Martucci Johnson
Ms. Sabrina Martucci Johnson
Independent Supervisory Director
Independent Supervisory Director
--
--
Dr. Amir Kalali
Dr. Amir Kalali
Independent Supervisory Director
Independent Supervisory Director
--
--
Dr. Srinivas Rao, M.D., Ph.D.
Dr. Srinivas Rao, M.D., Ph.D.
Chief Executive Officer, Co-Founder, Interim Managing Director
Chief Executive Officer, Co-Founder, Interim Managing Director
--
--
よくある質問
ATAI Life Sciences NVの上位5名の株主は誰ですか？
ATAI Life Sciences NVの上位5名の株主は以下のとおりです。Dr. Glenn Frank Short, Ph.D.
ATAI Life Sciences NV（ATAI）の株式を保有している機関の数はいくつですか？
2026Q1時点で、ATAI Life Sciences NVの株式を保有している機関は296社あり、保有株式の総市場価値は約73.07Mで、全体の19.93%を占めています。2025Q4と比較して、機関の持ち株は23428346.00増加しています。